Alpha Tau Medical (DRTS) Total Non-Current Liabilities (2020 - 2026)

Alpha Tau Medical's (DRTS) quarterly Total Non-Current Liabilities came in at $29.0 million in Q1 2026, up 95.28% year-on-year from $14.8 million in Q1 2025, and up 60.55% quarter-over-quarter from $18.0 million in Q4 2025.

Alpha Tau Medical (DRTS) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Alpha Tau Medical has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $29.0 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $29.0 million, up 95.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.0 million (up 95.28% YoY), and the FY2025 annual result was $18.0 million, up 21.42% from the prior year.
  • Total Non-Current Liabilities came in at $29.0 million for Q1 2026 at Alpha Tau Medical, up from $18.0 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $29.0 million in Q1 2026 to a low of $10.2 million in Q4 2022.
  • The 5-year median for Total Non-Current Liabilities is $15.3 million (2024), against an average of $15.7 million.
  • Across the five-year window, Total Non-Current Liabilities surged 130.51% in 2022 and slipped 9.41% in 2025, its largest moves.
  • Alpha Tau Medical's Total Non-Current Liabilities stood at $10.2 million in 2022, then jumped by 55.71% to $15.8 million in 2023, then decreased by 6.0% to $14.9 million in 2024, then increased by 21.42% to $18.0 million in 2025, then surged by 60.55% to $29.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $29.0 million (Q1 2026), $18.0 million (Q4 2025), and $18.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 42,980.09
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 11.03 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 644,700.00
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 5.87 Bn
9 Abivax 95.45 Bn 95.45 Bn - 64.76 Mn
10 Alpha Tau Medical 2,384.20 -76.42 Mn - 28.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.97 Mn
Dec 31, 2025 18.05 Mn
Sep 30, 2025 17.97 Mn
Jun 30, 2025 16.18 Mn
Mar 31, 2025 14.84 Mn
Dec 31, 2024 14.86 Mn
Sep 30, 2024 14.98 Mn
Jun 30, 2024 15.58 Mn
Mar 31, 2024 16.38 Mn
Dec 31, 2023 15.81 Mn
Sep 30, 2023 10.65 Mn
Jun 30, 2023 13.23 Mn
Mar 31, 2023 11.55 Mn
Dec 31, 2022 10.15 Mn
Dec 31, 2021 4.41 Mn
Dec 31, 2020 2.09 Mn